Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation

Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: Part I. Biology of Relapse after Transplantation

(2013) Ronald E. Gress et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Genomic loss of patient-specific HLA in acute myeloid leukemia relapse after well-matched unrelated donor HSCT

(2012) C. Toffalori et al.   BLOOD

Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies

(2012) P. Di Bartolomeo et al.   BLOOD

The EBMT activity survey: 1990–2010

(2012) J R Passweg et al.   BONE MARROW TRANSPLANTATION

Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia

(2012) Yu Wang et al.   CANCER

Different mechanisms causing loss of mismatched human leukocyte antigens in relapsing t(6;11)(q27;q23) acute myeloid leukemia after haploidentical transplantation

(2012) Hiroya Tamaki et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Leukemia specific loss of heterozygosity of MHC in a CLL patient: Disease state impacts timing of confirmatory typing

(2012) Myra Coppage et al.   HUMAN IMMUNOLOGY

Pretransplant HLA mistyping in diagnostic samples of acute myeloid leukemia patients due to acquired uniparental disomy

(2012) V Dubois et al.   LEUKEMIA

Genomic Loss of Mismatched Human Leukocyte Antigen and Leukemia Immune Escape From Haploidentical Graft-Versus-Leukemia

(2012) Luca Vago et al.   SEMINARS IN ONCOLOGY

Post-Transplantation Cyclophosphamide for Tolerance Induction in HLA-Haploidentical Bone Marrow Transplantation

(2012) Leo Luznik et al.   SEMINARS IN ONCOLOGY

Somatic mutations in the HLA genes of patients with hematological malignancy

(2012) A. G. Smith et al.   TISSUE ANTIGENS

Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML)

(2011) Friederike Schneider et al.   ANNALS OF HEMATOLOGY

Genome-wide Profiling in AML Patients Relapsing after Allogeneic Hematopoietic Cell Transplantation

(2011) Miguel Waterhouse et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell Transplantation

(2010) Steven Z. Pavletic et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Relapse of leukemia with loss of mismatched HLA resulting from uniparental disomy after haploidentical hematopoietic stem cell transplantation

(2010) I. B. Villalobos et al.   BLOOD

Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation

(2010) Ted A. Gooley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Age-Specific Differences in Oncogenic Pathway Dysregulation in Patients With Acute Myeloid Leukemia

(2009) Arati V. Rao et al.   JOURNAL OF CLINICAL ONCOLOGY

Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I–II study

(2009) Fabio Ciceri et al.   LANCET ONCOLOGY

Loss of Mismatched HLA in Leukemia after Stem-Cell Transplantation

(2009) Luca Vago et al.   NEW ENGLAND JOURNAL OF MEDICINE

Segmental uniparental disomy is a commonly acquired genetic event in relapsed acute myeloid leukemia

(2008) M. Raghavan et al.   BLOOD

Graft-versus-leukemia effects of transplantation and donor lymphocytes

(2008) H.-J. Kolb   BLOOD

Optimal HLA matching in hematopoietic cell transplantation

(2008) Effie W Petersdorf   CURRENT OPINION IN IMMUNOLOGY

Novel regions of acquired uniparental disomy discovered in acute myeloid leukemia

(2008) Manu Gupta et al.   GENES CHROMOSOMES & CANCER

Genomic typing for patient-specific human leukocyte antigen-alleles is an efficient tool for relapse detection of high-risk hematopoietic malignancies after stem cell transplantation from alternative donors

(2008) B Mazzi et al.   LEUKEMIA